1. 518 A multicenter prospective single-arm study to assess the predictive biomarkers of PSK responder from the analysis of cytokine promoter gene polymorphisms in patients with stage II or III colorectal cancer. (September 2015) Authors: Nishimura, T.; Yoshino, S.; Sakata, K.; Furuya, T.; Inoue, K.; Saeki, T.; Takemoto, K.; Etoh, R.; Kawaoka, T.; Hasegawa, H.; Kondo, H.; Araki, A.; Kudo, A.; Hashimoto, K.; Uchiyama, T.; Yamamoto, T.; Inoue, Y.; Okayama, N.; Hazama, S.; Nagano, H. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 530 A phase II study of cancer vaccination using three peptides combination with gemcitabine as a first-line therapy for advanced pancreatic cancer (VENUS-PC study). (September 2015) Authors: Iguchi, H.; Suzuki, N.; Uesugi, K.; Tanaka, H.; Hirakawa, K.; Aruga, A.; Hatori, T.; Ishizaki, H.; Umeda, Y.; Fujiwara, T.; Shimada, M.; Ikemoto, T.; Yoshimatsu, K.; Shimizu, R.; Hayashi, H.; Sakata, K.; Yoshino, S.; Furukawa, H.; Hazama, S.; Oka, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗